{"id":719,"date":"2014-04-24T07:24:54","date_gmt":"2014-04-24T07:24:54","guid":{"rendered":"https:\/\/mimr-phi.org\/?page_id=719"},"modified":"2026-04-16T15:25:44","modified_gmt":"2026-04-16T05:25:44","slug":"facilities","status":"publish","type":"page","link":"https:\/\/hudson.org.au\/facilities\/","title":{"rendered":"Technology platforms and capabilities"},"content":{"rendered":"\n
\n \"Scientist
\n
\n
\n <\/div>\n
\n
\n
\n
\n

Our pursuit of excellence is underpinned by world-leading capabilities and expertise through our integrated network of Technology Platforms.<\/p>\n <\/div>\n <\/div>\n

<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n
\n
\n
\n\n
\n
\n
\n\n
\"Natalia<\/a><\/figure>\n\n\n\n

RNAte Technology Platform<\/h2>\n\n\n\n
\"\"<\/a><\/figure>\n\n\n\n
<\/div>\n\n\n\n

Leveraging robotic automation in testing services enables high throughput applications for library screening or testing of different conditions, thereby aiding the optimisation of new product development. Using iPSC models can reduce the risk of clinical trials failure and has the potential to accelerate the development of new RNA and mRNA products in the manufacturing pipeline.<\/p>\n\n\n\n

The RNAte platform is designed to address the need for testing the immunoreactivity of RNA-based products, especially in established human cell models. The platform places a high priority on human induced pluripotent stem cell (iPSC) models for sensitive and accurate detection of immune responses.<\/p>\n\n\n\n

\n
Learn more<\/a><\/div>\n<\/div>\n\n\n\n

General enquiries \u00a0<\/strong>enquiry@rnate.com.au<\/a><\/p>\n\n\n\n

\n
RNATE WEBSITE<\/a><\/div>\n<\/div>\n\n<\/div>\n <\/div>\n<\/div>\n\n\n\n
\n
\n
\n\n
\"Cell<\/a><\/figure>\n\n\n\n

Hudson Institute Cell Therapies<\/h2>\n\n\n\n
<\/div>\n\n\n\n

Accredited Cell Therapy Processing and Cryopreservation Facility in Melbourne<\/strong><\/p>\n\n\n\n

Hudson Institute Cell Therapies (HICT) offers a purpose-built facility for the safe, efficient, and compliant processing and cryopreservation of human blood and tissue products\u2014serving the needs of clinicians, researchers, and industry partners involved in cell and gene therapy. Designed to improve accessibility and streamline clinical workflows, the facility enables the processing of blood products outside the Melbourne CBD, supporting clinical trials both within the Monash Medical Centre Precinct and at other trial sites across Australia.<\/p>\n\n\n\n

Operating within a PC2 and ISO 8 certified cleanroom environment, HICT houses a dedicated cryopreservation suite managed under ISO 15189 standards. The facility is accredited to receive, store, and distribute human cellular therapy products, providing essential support for multi-site clinical cell therapy trials and cell therapy services. With a strong focus on quality, safety, and accessibility, Hudson Institute Cell Therapies supports the advancement of cellular therapies through robust infrastructure and close integration with clinical care.<\/p>\n\n\n\n

\n
Learn more<\/a><\/div>\n\n\n\n
Hudson cell therapies website<\/a><\/div>\n<\/div>\n\n\n\n

General enquiries <\/strong>CellTherapies@hudson.org.au<\/a><\/p>\n\n<\/div>\n <\/div>\n<\/div>\n\n\n\n

\n
\n
\n\n
\"Flow<\/a><\/figure>\n\n\n\n

Flow Cytometry<\/h2>\n\n\n\n
<\/div>\n\n\n\n

FlowCore MHTP provides flow cytometry services to researchers within MHTP and the wider scientific community.Download PDF Flowcore<\/p>\n\n\n\n

Flow cytometry is a high-speed laser-based technology enabling users to generate multiparametric data about cell characteristics or particles of interest based upon fluorescent probes and markers. It is a powerful tool in many fields including immunology, stem cell science, cancer research, aquatic and plant biology.<\/p>\n\n\n\n

The facility currently operates one high-speed cell sorter as well as one conventional and two spectral flow cytometers. FlowCore MHTP provides the following services on a fee-for-service model:<\/p>\n\n\n\n